Hepatobiliary Surgery — MCQs

Hepatobiliary Surgery Indian Medical PG Practice Questions and MCQs

Question 511: In a patient with acute cholangitis, what is the most effective initial procedure to achieve biliary drainage and relieve obstruction?

A. Endoscopic retrograde cholangiopancreatography (ERCP) (Correct Answer)
B. Percutaneous transhepatic cholangiography (PTC) for biliary drainage
C. Laparoscopic cholecystectomy for gallbladder disease
D. Antibiotics for infection control

Explanation: ***Endoscopic retrograde cholangiopancreatography (ERCP)*** - **ERCP** is the most effective initial treatment because it allows for direct visualization of the **biliary tree**, removal of obstructions (e.g., gallstones), and placement of stents for drainage. - This procedure provides immediate relief of **biliary obstruction**, which is crucial in managing acute cholangitis and preventing further complications. *Percutaneous transhepatic cholangiography (PTC) for biliary drainage* - **PTC** is a viable alternative if ERCP is unsuccessful or contraindicated, but it is generally considered a second-line option due to its more invasive nature and higher risk profile. - While it can provide effective **biliary drainage**, it does not allow for direct stone extraction or definitive treatment of the obstruction in the same way ERCP does. *Laparoscopic cholecystectomy for gallbladder disease* - **Laparoscopic cholecystectomy** is indicated for **gallbladder disease** but is typically performed electively after the acute phase of cholangitis has resolved. - Performing cholecystectomy during active cholangitis carries a much higher risk of complications and does not immediately address the acute **biliary obstruction**. *Antibiotics for infection control* - **Antibiotics** are essential for managing the infection associated with cholangitis but do not directly relieve the **biliary obstruction**. - While crucial for systemic control, antibiotics alone will not resolve the underlying problem of blocked bile flow, which is the primary driver of the acute attack.

Question 512: In planning liver resection for a patient with hepatocellular carcinoma (HCC) and cirrhosis, which factors must be evaluated to optimize outcomes?

A. Liver function tests, portal pressure measurements, and future liver remnant volume (Correct Answer)
B. Only tumor size
C. Patient preference for surgical intervention
D. Availability of liver transplantation

Explanation: ***Liver function tests, portal pressure measurements, and future liver remnant volume*** - **Liver function tests**, specifically the Child-Pugh score or MELD score, are crucial for assessing the liver's synthetic capacity and overall health, which directly impacts the safety of resection in cirrhotic patients. - **Portal pressure measurements** (e.g., hepatic venous pressure gradient) help identify patients at higher risk of postoperative decompensation due to **portal hypertension**, while **future liver remnant (FLR) volume** ensures that sufficient functioning liver tissue remains after resection to avoid **post-hepatectomy liver failure**. *Only tumor size* - While **tumor size** is an important factor for prognosis and surgical planning, it is not the sole determinant for optimizing outcomes in HCC patients with cirrhosis. - Ignoring critical aspects of liver function and morphology in cirrhotic patients would lead to **high rates of postoperative complications** and mortality. *Patient preference for surgical intervention* - **Patient preference** is important for informed consent and shared decision-making but is not a clinical factor that directly optimizes surgical outcomes or determines resectability. - Surgical candidacy is primarily dictated by **oncological and physiological parameters**, not patient preference. *Availability of liver transplantation* - **Liver transplantation** is a treatment option for HCC in cirrhotic patients but its availability does not directly influence the resectability or safety of a planned **liver resection**. - The assessment of **resection candidacy** is based on the patient's current liver function and tumor characteristics, independent of whether a transplant center is nearby.

Question 513: A 64-year-old woman with a history of chronic pancreatitis presents with sudden severe abdominal pain. A CT scan shows a pseudocyst compressing the bile duct. What is the most appropriate initial management?

A. ERCP with stent placement (Correct Answer)
B. Observation
C. Percutaneous drainage
D. Surgical cystogastrostomy

Explanation: ***ERCP with stent placement*** - **ERCP with biliary stent placement** provides **immediate relief of biliary obstruction** caused by the pseudocyst compressing the bile duct, preventing complications such as **cholangitis** and **progressive jaundice**. - This is an appropriate **initial intervention** to decompress the biliary system while planning **definitive management** of the pseudocyst (endoscopic or surgical drainage once the pseudocyst is mature). - It is **minimally invasive** and can be performed urgently if the patient has signs of biliary obstruction. - Note: Definitive treatment requires **drainage of the pseudocyst itself** (endoscopic cystogastrostomy or surgical approach) once it has matured (typically >6 weeks). *Observation* - **Observation** is inappropriate for **symptomatic bile duct compression** as it can lead to serious complications including **cholangitis**, **secondary biliary cirrhosis**, and **hepatic dysfunction**. - Active intervention is required to prevent biliary sepsis and progressive liver damage. *Percutaneous drainage* - **Percutaneous drainage** addresses the **pseudocyst** but is associated with higher risks of **infection**, **external fistula formation**, and **recurrence** compared to endoscopic or surgical approaches. - It may be considered for **infected pseudocysts** or when endoscopic/surgical options are not available, but is not the preferred initial management for biliary obstruction. *Surgical cystogastrostomy* - **Surgical cystogastrostomy** is a **definitive treatment** for symptomatic pseudocysts and can address both the pseudocyst and biliary obstruction simultaneously. - However, it is **more invasive** than endoscopic approaches and is typically reserved for cases where endoscopic management fails, the pseudocyst is not amenable to endoscopic drainage, or there are other indications for surgery. - It is not the **first-line initial management** given the availability of less invasive endoscopic options for urgent biliary decompression.

Question 514: Which of the following is TRUE regarding gallbladder cancer?

A. Adenocarcinoma is the most common type of gallbladder cancer (Correct Answer)
B. Squamous cell carcinoma is the most common type
C. It commonly presents with early symptoms
D. It has an excellent prognosis with 5-year survival >70%

Explanation: ***Adenocarcinoma is the most common type of gallbladder cancer*** - This statement is correct as **adenocarcinoma accounts for approximately 90%** of all gallbladder cancers. - It arises from the **glandular cells** lining the gallbladder. - The other histological types include squamous cell carcinoma, adenosquamous carcinoma, and small cell carcinoma, but these are much rarer. *Squamous cell carcinoma is the most common type* - This is incorrect. Squamous cell carcinoma accounts for only **1-5%** of gallbladder cancers. - Adenocarcinoma is by far the **predominant histological type**. *It commonly presents with early symptoms* - This is incorrect. Gallbladder cancer typically presents **late** because early symptoms are vague or absent. - Common late presentations include **jaundice, right upper quadrant pain, and palpable mass**. - The lack of early symptoms contributes to poor prognosis. *It has an excellent prognosis with 5-year survival >70%* - This is incorrect. Gallbladder cancer has a **poor prognosis** with overall 5-year survival rate of **less than 20%**. - This is due to **late detection, aggressive nature**, and tendency for early local invasion and distant metastasis.

Question 515: What is an excellent predictor of mortality and morbidity in patients after hepatectomy?

A. Serum lactate levels (Correct Answer)
B. Serum magnesium level
C. Serum iron level
D. Serum copper level

Explanation: **Serum lactate levels (Correct)** - Elevated serum lactate after hepatectomy indicates **tissue hypoperfusion** and **anaerobic metabolism**, reflecting significant physiological stress and potential organ dysfunction - High lactate levels are strongly correlated with **postoperative complications** and increased mortality due to impaired hepatic clearance and widespread cellular injury - The liver is the primary organ for lactate clearance, making lactate levels an excellent marker of hepatic function and overall physiological stress after hepatectomy *Serum magnesium level (Incorrect)* - While magnesium is vital for many enzymatic reactions, its direct predictive value for overall mortality and morbidity after hepatectomy is less established compared to lactate - Significant derangements in magnesium might indicate underlying issues but are not primary markers of acute organ stress or hypoperfusion *Serum iron level (Incorrect)* - Iron levels are typically associated with conditions like anemia or iron overload syndrome and do not directly reflect acute postoperative stress, tissue hypoperfusion, or immediate surgical outcomes - Iron metabolism is important for long-term health but is not a sensitive or specific predictor of short-term mortality after hepatectomy *Serum copper level (Incorrect)* - Copper is an essential trace element, but its serum levels are not routinely used as a predictor of acute postoperative mortality or morbidity after major surgery like hepatectomy - Dysregulation of copper levels is more commonly associated with specific genetic disorders (like Wilson's disease) or chronic conditions, rather than immediate surgical complications

Question 516: A patient presented with right hypochondriac pain. He had an episode of diarrhea 1 week prior. CT scan of the abdomen reveals a liver abscess of around 25 cc. What is the next step in management?

A. PAIR
B. Surgery
C. Medical therapy (Correct Answer)
D. Percutaneous drainage

Explanation: ***Medical therapy*** - This is the appropriate next step for a **small liver abscess** of 25 cc (approximately 2.9 cm diameter). - Current evidence-based guidelines recommend **medical therapy alone** for abscesses **<5 cm in diameter**. - The preceding diarrheal episode suggests **amebic liver abscess**, which responds excellently to **metronidazole** with drainage reserved for non-responders. - Success rate with medical therapy alone for small abscesses is **>85%**. - Percutaneous drainage is reserved for: abscesses >5 cm, failed medical therapy (no improvement in 4-7 days), left lobe location, or imminent rupture. *Percutaneous drainage* - This would be indicated for **larger abscesses (>5 cm)**, left lobe abscesses, or if medical therapy fails after 4-7 days. - For a **small 25 cc abscess**, immediate drainage is unnecessary and carries procedural risks without added benefit. - Drainage should be considered if fever persists beyond 72 hours of appropriate antibiotics or clinical deterioration occurs. *PAIR* - **PAIR (Puncture, Aspiration, Injection, Re-aspiration)** is specifically for **hydatid cysts**, not pyogenic or amebic liver abscesses. - Injecting scolicidal agents would be inappropriate and potentially harmful in non-hydatid pathology. *Surgery* - Surgical drainage is reserved for **complicated cases**: ruptured abscess, multiple/loculated collections failing percutaneous drainage, or thick-walled abscesses. - A small, uncomplicated 25 cc abscess does not warrant surgical intervention as first-line management.

Question 517: A patient with multiple gallstones presents with an 8 mm dilation of the common bile duct (CBD) and 4 stones in the CBD. What is the best treatment modality?

A. ESWL
B. Cholecystectomy with choledocholithotomy at the same setting
C. None of the options
D. ERCP with stone extraction followed by laparoscopic cholecystectomy (Correct Answer)

Explanation: ***ERCP with stone extraction followed by laparoscopic cholecystectomy*** - This approach addresses both the **common bile duct (CBD) stones** and the **gallbladder stones** effectively, which is crucial given the dilated CBD and multiple stones. - **ERCP (endoscopic retrograde cholangiopancreatography)** allows for the removal of CBD stones, preventing complications like **cholangitis** or **pancreatitis**, while **laparoscopic cholecystectomy** removes the source of stone formation (the gallbladder). *Cholecystectomy with choledocholithotomy at the same setting* - While this addresses both issues, performing an open **choledocholithotomy** can be more invasive and is typically reserved for cases where ERCP is not feasible or fails. - The patient's presentation does not indicate an immediate need for an open procedure, and a less invasive approach is generally preferred. *ESWL* - **ESWL (extracorporeal shock wave lithotripsy)** is generally used for **renal stones** or sometimes for large, solitary **gallbladder stones**, but it is not the primary treatment for multiple CBD stones. - It does not remove the gallbladder, leaving the source of stone formation intact and risking further CBD stone recurrence. *None of the options* - This is incorrect as there is a clear and effective treatment strategy for this patient's condition.

Question 518: What is the most important presenting feature of periampullary carcinoma?

A. Jaundice (Correct Answer)
B. Abdominal Pain
C. Unintentional Weight Loss
D. Palpable Abdominal Mass

Explanation: ***Jaundice*** - **Painless obstructive jaundice** is the hallmark symptom, occurring early due to the tumor's proximity to the common bile duct. - The obstruction of bile flow leads to the accumulation of **bilirubin**, causing yellow discoloration of the skin and eyes. *Abdominal Pain* - While **abdominal pain** can occur, it is often a later symptom and is less specific than jaundice for early diagnosis. - Pain typically arises from tumor growth, invasion of surrounding structures, or pancreatic involvement. *Unintentional Weight Loss* - **Unintentional weight loss** is a common constitutional symptom of many advanced malignancies, including periampullary carcinoma. - However, it usually manifests at a later stage and is not the initial, specific presenting feature that prompts investigation. *Palpable Abdominal Mass* - A **palpable abdominal mass** is rare in early periampullary carcinoma, as these tumors are typically small and deeply seated. - Its presence usually indicates advanced disease with significant tumor burden or metastasis.

Question 519: A 60-year-old male presented with jaundice, pale stools, dark urine, and a mass in the epigastric region. Which of the following diagnoses is least likely to be the cause of these symptoms?

A. Biliary Cancer
B. Periampullary Cancer
C. Pancreatic Cancer
D. Chronic Cholecystitis (Correct Answer)

Explanation: ***Chronic Cholecystitis*** - While chronic cholecystitis can cause epigastric pain, it rarely presents with **jaundice**, **pale stools**, and **dark urine** because it typically does not obstruct the common bile duct. - The presence of a palpable **epigastric mass** is also not a common feature of chronic cholecystitis. *Biliary Cancer* - **Biliary cancer**, particularly choledochal cancer, can cause **obstructive jaundice**, leading to **pale stools** (lack of bilirubin) and **dark urine** (conjugated bilirubin in urine). - A mass in the **epigastric region** could represent an enlarged gallbladder due to distal obstruction (Courvoisier's sign) or the tumor itself. *Periampullary Cancer* - **Periampullary cancers**, which arise near the ampulla of Vater, characteristically cause **obstructive jaundice**, presenting with **pale stools** and **dark urine**. - A mass in the **epigastric region** might be the tumor or a dilated gallbladder due to bile duct obstruction. *Pancreatic cancer* - **Pancreatic head cancer** frequently obstructs the common bile duct, resulting in **jaundice**, **pale stools**, and **dark urine**. - An **epigastric mass** can be the palpable tumor itself or an enlarged, distended gallbladder.

Question 520: Treatment of choice for mucinous carcinoma of the gall bladder in the early stage is -

A. Simple cholecystectomy (Correct Answer)
B. Extended cholecystectomy
C. Cholecystectomy with wedge resection of liver
D. Chemotherapy only

Explanation: ***Simple cholecystectomy*** - For **early-stage (T1a) mucinous carcinoma of the gallbladder**, **simple cholecystectomy** is the treatment of choice - T1a disease (tumor confined to mucosa) has an excellent prognosis with **5-year survival >90%** after simple cholecystectomy alone - Extended resection offers **no survival benefit** for T1a disease and increases surgical morbidity - If incidentally discovered post-cholecystectomy with negative margins, no further surgery is needed *Extended cholecystectomy* - **Extended cholecystectomy** (cholecystectomy + liver segments IVb/V resection + portal lymphadenectomy) is indicated for **T2 or higher stage** disease (tumor invading muscularis propria or beyond) - This is **not** the treatment for early-stage disease as it increases morbidity without survival benefit - Reserved for more advanced tumors with deeper invasion *Cholecystectomy with wedge resection of liver* - This describes a component of extended cholecystectomy and is similarly indicated for **T2+ disease**, not early-stage - Wedge resection aims to achieve negative margins when tumor extends beyond the gallbladder wall - Not appropriate for early-stage mucinous carcinoma confined to mucosa *Chemotherapy only* - **Chemotherapy alone** is not curative for early-stage gallbladder carcinoma - Surgery remains the primary curative treatment for resectable disease - Chemotherapy is reserved for advanced, metastatic, or unresectable disease as palliative treatment

Practice by Chapter

Liver Anatomy and Physiology

Practice Questions

Benign Liver Lesions

Practice Questions

Liver Abscess

Practice Questions

Hepatocellular Carcinoma

Practice Questions

Metastatic Liver Disease

Practice Questions

Cirrhosis and Portal Hypertension

Practice Questions

Liver Trauma

Practice Questions

Cholelithiasis and Cholecystitis

Practice Questions

Choledocholithiasis

Practice Questions

Biliary Tract Tumors

Practice Questions

ERCP and Its Complications

Practice Questions

Liver Transplantation Basics

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free